| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 22 |
| 1 | ASPIRIN 325 MG | 22 |
| 2 | ASPIRIN 81 MG | 22 |
| 3 | CLOPIDOGREL BISULFATE | 17 |
| 4 | CLOPIDOGREL | 16 |
| 5 | GABAPENTIN | 13 |
| 6 | ERGOCALCIFEROL | 12 |
| 7 | FUROSEMIDE | 11 |
| 8 | LEVOTHYROXINE SODIUM | 11 |
| 9 | MIDAZOLAM | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | COCAINE HYDROCHLORIDE NASAL | 2 | 0.0308 |
| 1 | MEPIVACAINE HYDROCHLORIDE | 8 | 0.0069 |
| 2 | FLUTAMIDE | 2 | 0.0020 |
| 3 | ARGATROBAN | 3 | 0.0020 |
| 4 | ANTIHEMOPHILIC FACTOR HUMAN | 2 | 0.0015 |
| 5 | ISAVUCONAZONIUM SULFATE | 5 | 0.0013 |
| 6 | CALCIUM CHLORIDE INJECTION | 4 | 0.0013 |
| 7 | ANAGRELIDE HYDROCHLORIDE | 1 | 0.0009 |
| 8 | ALTEPLASE | 10 | 0.0007 |
| 9 | CAPTOPRIL | 5 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 38 |
| 1 | Corticosteroid [EPC] | 24 |
| 2 | Platelet Aggregation Inhibitor [EPC] | 22 |
| 3 | Benzodiazepine [EPC] | 17 |
| 4 | Kinase Inhibitor [EPC] | 15 |
| 5 | Opioid Agonist [EPC] | 14 |
| 6 | Phosphodiesterase 5 Inhibitor [EPC] | 14 |
| 7 | Factor Xa Inhibitor [EPC] | 13 |
| 8 | beta-Adrenergic Blocker [EPC] | 13 |
| 9 | Central Nervous System Stimulant [EPC] | 12 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anti-coagulant [EPC] | 4 | 0.0011 |
| 1 | Prostacycline [EPC] | 1 | 0.0011 |
| 2 | Provitamin D2 Compound [EPC] | 12 | 0.0004 |
| 3 | Phosphodiesterase 3 Inhibitor [EPC] | 2 | 0.0003 |
| 4 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 2 | 0.0003 |
| 5 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 2 | 0.0002 |
| 6 | Quinolone Antimicrobial [EPC] | 2 | 0.0002 |
| 7 | Epidermal Growth Factor Receptor Antagonist [EPC] | 8 | 0.0002 |
| 8 | Cardiac Myosin Inhibitor [EPC] | 1 | 0.0002 |
| 9 | CD52-directed Cytolytic Antibody [EPC] | 3 | 0.0002 |